P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT. (23rd June 2022) - Xavier-Ferrucio, J.; Luo, C.; Angelini, G.; Krishnamurthy, S.; Patel, N.; Pettiglio, M.; Collingsworth, T.; Isik, M.; Ghodssi, A.; Halfond, A.; Etchin, J.; Keschner, Y.; et al.